Evidence map›Paper›PMID 39452751›Full record

ArticlePathogens (Basel, Switzerland)2024

Clinical Identification of Two Novel

Nan Xiao, Xiu-Ying Zhao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Emerging mastitis-associatedFrontiers in cellular and infection microbiology · 2025
    Article
  4. Clinical review and drug sensitivity test ofFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nan XiaoDepartment of Laboratory Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 100190, China.ORCID 0000-0002-2798-4914
Xiu-Ying ZhaoDepartment of Laboratory Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 100190, China.

Funding

Beijing High-level Public Health Technical Personnel Project 2023-03-03
6 · The paper itself

Abstract

Granulomatous lobular mastitis (GLM) is a rare benign breast inflammatory disease that affects women of childbearing age.

Indexed as

Anti-Bacterial AgentsCorynebacteriumCorynebacterium InfectionsGranulomatous MastitisPhylogenyAdultDNA, BacterialFemaleHumansMicrobial Sensitivity TestsRNA, Ribosomal, 16SSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAnti-Bacterial AgentsDNA, BacterialRNA, Ribosomal, 16Santibiotic sensitivity tests (AST)C. kroppenstedtiigranulomatous lobular mastitis (GLM)Mass Spectral Peaks (MSPs)rpoB

Identifiers

PMID39452751
PMCPMC11514597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.